Sunday, 27 November 2016

Biosimilars Asia 2017

About Conference

The Organizing Committee is delighted to invite you to attend the 8th Asian Biosimilars Congress one of its remarkable Pharmaceutical conferences, to be held during August 10-12, 2017 at Beijing, China. Asian Biosimilars Congress 2017 brings together scientists, researchers and CROs from around the world. With the approval of second biosimilar by the USFDA-Inflectra, the biosimilars market is owned to experience an exponential growth over the coming few years. Many biologics products are making their entry in the pharma market and experiencing a notable rise in their usage over the conventional medications.
At Asian Biosimilars 2017 meet your target audiences from around the world focused on learning about biologics and biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and biosimilars community.
Why to attend???
Join your peers around the world focused on learning about Biologics and Biosimilars related advances, which is your single best opportunity to reach the largest assemblage of participants from the Biosimilars community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Biologics and Biosimilars are hallmarks of this conference. 
Target Audience: 
  • Students, Scientists, Researchers, and Faculty of Pharmaceutical Sciences
  • Universities, Medical Colleges, Researchers from Pharmaceutical backgrounds
  • Pharma Industry, Pharmacy Associations and Societies
  • Business Entrepreneurs, Training Institutes, Software developing companies
  • Medical Devices Manufacturing Companies, CRO
  • Data Management Companies. 

Conference Highlights

  • Latest Biosimilars in Asian Scenario
  • Biosimilars- Hatch-Waxman Act & BPCI Act
  • Challenges in Developing Biosimilars
  • Biosimilars Research Pipeline
  • Current Developments in The Field of Biosimilars
  • Pharmacovigilance of Biosimilars
  • Emerging Trends in Biosimilars
  • Biosimilars Market- Challenges & Prospects
  • Cost Analysis of Biosimilars
  • Globalization of Biosimilars
  • Biosimilars Analytical Strategies
  • Emerging Biosimilars in Therapeutics
  • Clinical Studies on Biosimilars
  • BCS & IVIVC Based Biowaivers
  • Entrepreneurs Investment Meet

Special Issues

All accepted abstracts will be published in respective Journals.
Abstracts will be provided with Digital Object Identifier by Cross Ref.

See more at: